3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Lymphoma
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Malignant Solid Neoplasm
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Interventions
Specimen Handling
5
Biopsy
5
Magnetic Resonance Spectroscopy
4
Cyclophosphamide
3
sodium-iodide symporter
2
ruxolitinib
2
duvelisib
2
cemiplimab
2
X-Rays
2
Vincristine
2
Prednisone
2
Photons
2
Immunoglobulin G
2
Etoposide
2
Doxorubicin
2
Disulfides
2
prednylidene
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Stem Cell Transplantation
1
Standard of Care
1
Practice Guidelines as Topic
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Nivolumab
1
Melphalan
1
Leukapheresis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
copanlisib
×
30 days
×
Clear all
No trials found.